Found: 11
Select item for more details and to access through your institution.
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies.
- Published in:
- Rheumatology, 2017, v. 56, n. 1, p. 46, doi. 10.1093/rheumatology/kew329
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 5, p. 756, doi. 10.1080/14397595.2018.1553489
- By:
- Publication type:
- Article
Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1804, doi. 10.1093/rheumatology/keac477
- By:
- Publication type:
- Article
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 9, p. 1450, doi. 10.1002/art.40911
- By:
- Publication type:
- Article
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 1, p. 283, doi. 10.1007/s40744-018-0097-3
- By:
- Publication type:
- Article
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2127, doi. 10.1007/s10067-020-04956-1
- By:
- Publication type:
- Article
Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1866-2
- By:
- Publication type:
- Article